VeraDermics Inc. Secures Licensing of First-in-Class Antiviral Targeting the Treatment of Molluscum Contagiosum and other Poxviruses
This Startup Raised $20.7 Million To Develop A Kid-Friendly Wart Treatment
Why Are We Still Killing Warts the Way We Did in the 1950s? Rethinking a pesky condition.
Kansas City dermatologist launches startup to address common childhood ailment